0 (0%) | 04-18 23:07 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 13.71 | 1-year : | 14.08 |
Resists | First : | 11.74 | Second : | 12.06 |
Pivot price | 11.66 | |||
Supports | First : | 11.22 | Second : | 9.34 |
MAs | MA(5) : | 11.36 | MA(20) : | 11.73 |
MA(100) : | 11.65 | MA(250) : | 11.3 | |
MACD | MACD : | -0.2 | Signal : | -0.1 |
%K %D | K(14,3) : | 12 | D(3) : | 9 |
RSI | RSI(14): 27.1 | |||
52-week | High : | 12.06 | Low : | 10.14 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ PGX ] has closed above bottom band by 11.9%. Bollinger Bands are 149.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.
If tomorrow: | Open lower | Open higher |
High: | 11.42 - 11.48 | 11.48 - 11.53 |
Low: | 11.09 - 11.18 | 11.18 - 11.26 |
Close: | 11.18 - 11.31 | 11.31 - 11.42 |
Thu, 04 Apr 2024
Cortex Appoints Randy Henderson as Chairman of the Board - Yahoo Lifestyle UK
Wed, 06 Dec 2023
New Zealand protests continue against genocide in Gaza as new far-right government backs Israel - WSWS
Tue, 22 Nov 2022
Clinical Evidence Shows Reduced Costs and Improved Outcomes in Heart Transplantation - BioSpace
Thu, 07 Apr 2022
Lantheus Stock: Bullish Both In The Near And Long Term (NASDAQ:LNTH) - Seeking Alpha
Mon, 22 Jun 2020
Lantheus, Progenics complete merger - Mass Device
Mon, 22 Jun 2020
Lantheus Completes Merger with Progenics - Business Wire
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 0 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 0 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |